IR/IGF-1 receptor hybrids and IR-A lead to an over-activation of the IGF pathway, causing an enhanced mitogenic signaling and cancer development (Malaguarnera et al., 2011)
Contraindicated in patients with a history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia Syndromes (MEN 2) Consult your healthcare provider if you have a history of pancreatitis, as the medication may increase risk Serious side effects may involve hypoglycemia, kidney issues, or allergic reactions 1,5 Not suitable for individuals with type 1 diabetes or diabetic ketoacidosis Medication interactions may occur with those on insulin, oral diabetes medications, oral contraceptives, and blood thinners
Im still eating exactly the same, just less. (P5, female, obesity)
Related Products APLB APLB Tranexamic Acid Niacinamide Ampoule Serum 40ml APLB APLB Glutathione Niacinamide Sunscreen 40ml APLB APLB Azelaic Acid Peptide Ampoule Serum 40ml APLB APLB Salicylic Acid BHA Arbutin Ampoule Serum 40ml APLB
Consistent follow-up care is essential to ensuring PT-141 is working effectively and safely for you